Three TEIJIN CDMO facilities
in Japan provide CDMO
services to meet your various needs.
Kashiwa-no-ha Facility (since Feb, 2024)
"Kashiwa-no-ha Facility" serves as a core manufacturing function in Kashiwa-no-ha regenerative medicine platform in collaboration with National Cancer Center, Mitsui-Fudosan, and J-TEC. This platform provides one-stop service from early research and development to manufacturing of clinical supply and business strategy with seed holders of cell and gene therapy/regenerative medicine, so that we can contribute to producing innovative medical solutions for diseases with unmet medical needs.
Address
6-2, Kashiwanoha 6-chome, Kashiwa city,
Chiba 277-0882, Japan
Iwakuni Factory (Start operation in 2024.)
"Iwakuni Factrory" provides the integrated manufacturing services through the seamless linkage with Kashiwa-no-ha Facility, from scale-up/scale-out of clinical supply manufacturing to commercial supply manufacturing. We can support various needs of manufacturing such as gene transduction, mass-scale cell culture, and tissue culture.
We TEIJIN have experience in developing unique pharmaceuticals and medical devices in-house, establishing high-quality production technologies, and commercial supply chain in Japan and overseas. We provide commercial manufacturing services by fully utilizing well established know-hows.
Address
2-1, Hinodemachi, Iwakuni, Yamaguchi 740-8511, Japan
J-TEC (Founded in 1999)
Japan Tissue Engineering Co., Ltd. (J-TEC) is a regenerative medicine manufacturer with the vision of "Creating a Future for Regenerative Medicine", and has a full value chain from research and development, regulatory, manufacturing, sales, and post-marketing maintenance. J-TEC stably launches and supplies the autologous regenerative medical products (autologous cultured epidermis, autologous cultured cartilage, autologous cultured corneal epithelium, etc.).
Address
6-209-1 Miyakitadori, Gamagori, Aichi 443-0022, Japan